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Objective: This study aimed to determine whether the apparent
diffusion coefficients (ADCs) determined by diffusion-weighted
imaging (DWI) of magnetic resonance imaging (MRI) could facilitate
the malignancy grading of various gliomas.
Methods: Sixty patients with a primary cerebral glioma underwent
diffusion-weighted and gadolinium-enhanced (Gd) T1-weighted MRI
using a 1.5-T MRI scanner. Scoring was performed based on signal
intensities on DWI and Gd images. The mean and minimum ADC
values were calculated, and Ki-67 staining was performed for each
histological sample to evaluate their tumor proliferative potential.
Then, the DWI, Gd, and combined scores were analyzed and
compared with the Ki-67 staining index and malignant grade. The
relationships among the mean and minimum ADC values, Ki-67
staining index, and malignant grade were also evaluated.
Results: The minimum ADC was inversely correlated with the Ki-67
staining index, with a low minimum ADC suggestive of tumor
malignancy. The qualitative evaluation of the D score of water
molecule diffusion on DWI accurately reflected the pathological grades
of gliomas, with an effectiveness that was at least as good as the
quantitative analysis using the minimum ADC. The diagnostic value
of Gd images in determining glioma malignancy grades was inferior
to that of DWI.
Conclusion: Both DWI and gadolinium-enhanced images of MRI
should be considered essential for the diagnosis of tumor malignancy.
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Introduction

Magnetic resonance imaging (MRI) is an essential
diagnostic tool for brain tumors, with gadolinium-

enhanced T1-weighted MRI being one of the most
commonly used techniques. Diffusion-weighted
imaging (DWI) can visualize restrictions to
the free diffusion of water caused by tissue
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microstructure. Different histological tumor types
have different cellularity, leading to intensity
differences on DWI. The magnitude of diffusion
is represented by apparent diffusion coefficients
(ADCs), where a low ADC indicates a restricted
diffusion and is seen as a high signal intensity
on DWI. DWI is useful in the diagnosis of primary
malignant lymphoma because pathological tissues
demonstrate a small cell size and integrated cell
density [1].
A low ADC can demonstrate the malignant
properties of tumors [2–4], whereas others argued
that ADC is not useful [5–7], since the presence of
vascular edema, hemorrhage, and cystic alteration
causes ADC value heterogeneity, which can
compensate for the decrease in ADC. Therefore,
the range of interest (ROI) was placed in the most
solid tumor part to exclude edema, cystic changes,
and central necrosis [8].
The value of DWI findings in malignant
gliomas was described in the literature [1–15].
However, DWI findings was not sufficiently been
evaluated based on their histological proliferative
potential. Therefore, this study aimed: 1) to
determine whether mean and minimum ADCs
correlate with the malignant grades of gliomas;
2) to compare the pathological diagnosis with
DWI findings and evaluate whether DWI
correlates with glioma malignancy grades; and
3) to compare high DWI signal intensities,
gadolinium enhancement, and the combination
of both and evaluate which method shows the
highest correlation with glioma malignancy
grades.

2

Materials and methods

2.1 Patients
In this study, patients who underwent surgery
for glioma resection at Teikyo University Chiba

http://bsa.tsinghuajournals.com

Medical Center between January 2002 and
December 2014 were retrospectively included.
Patients without a preoperative MRI evaluation
were excluded. This study was a retrospective
analysis and approved by the ethics committee of
Teikyo University Chiba Medical Center. Data
were dealt with anonymously, and an informed
consent was obtained from each patient.
2.2 MRI protocol and analysis
Preoperative MRI was done using a Signa HDxt
1.5-T scanner (GE Healthcare, Waukesha, WI,
United State). Axial DWI slices were acquired
using the following parameters: TR, 6000 ms;
TE, 82.4 ms; FOV, 240 × 240 mm2; b = 1000 s/mm2;
slice thickness = 6 mm; slice spacing = 1.5 mm; and
matrix, 128 × 192. Then, ADC maps representing
voxel-level ADC measurements were created.
Contrast-enhanced MRI was performed with
0.2 mL/kg of meglumine gadopentetate (Magnevist
iv syringe, Bayer AG, Germany) or gadodiamide
hydrate (Omniscan iv syringe, Dai-ichi Sankyo
Co. Ltd., Japan) using the following parameters:
TR, 560 ms; TE, 11 ms; FOV, 240 × 240 mm2;
slice thickness, 6 mm; slice spacing, 1.5 mm; and
matrix, 448 × 224. Contrast-enhanced MRI was
also performed using axial, sagittal, and coronal
representations. MRI findings, including the signal
intensities on DWI and contrast enhancement,
were recorded by two radiologists.
An axial ADC map section displaying the
maximum size of the solid tumor part was
selected, and an ROI was set to define the tumor.
Susceptibility-weighted imaging (SWI) was also
done to evaluate intratumoral hemorrhages;
hypointense signals in SWI were regarded as
hemorrhage, and these, along with cystic components, were excluded. Then, the mean and
minimum ADC values of the tumor were recorded.
MR exponential images were used to eradicate
the T2 shine-through effect.
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The DWI results were scored with 0, representing tumors with a high signal intensity (even if
only a small portion showed a high intensity);
and 1, representing tumors without any portions
with high signal intensities. A high signal intensity
was defined as tumors with the same signal
intensity as cerebrospinal fluid on the ADC
map. For DWI scoring, areas with intratumoral
hemorrhage and cystic components were also
excluded. In this study, the DWI score was called
the D score. Contrast-enhanced MRI was scored
with 0, representing tumors with a high contrastenhanced intensity (even if only a small portion);
and 1, representing tumors with no enhancement;
patients with low contrast-enhanced intensities
were excluded because it would be difficult to
decide which score group they belong to. This
contrast-enhanced score was named the E score,
and the D and E scores were combined, being
then referred to as the DE score.
2.3 Evaluation of tumor proliferation
Histopathological diagnoses were performed by
two pathologists. Ki-67 staining was performed
to evaluate their proliferative potential. Paraffinembedded tissue sections were examined
immunohistochemically using mouse monoclonal
Ki-67 antibodies (Dako, Glostrup, Denmark;
1:25 dilution). Tissue sections were stained with
Ventana BenchMark ULTRA automated immunostainer using heat-induced epitope retrieval and
a standard diaminobenzidine (DAB) detection
kit (Ventana iVIEW DAB Universal Kit).
Pathological grading was categorized into
three groups (grade I–II, grade III, and grade IV)
because of a very low number of grade I tumors,
or into two groups (grade I–II, and grade III–IV,
i.e., benign and malignant glioma groups).
2.4 Statistical analysis
Data analyses were performed as follows:
1) correlations of the mean and minimum ADCs

with the Ki-67 staining index were examined;
2) correlations of the D, E, and DE scores with
the Ki-67 staining index were examined;
3) relationships of the mean and minimum ADCs
with the glioma grades were examined; and
4) correlations of pathological grades with the
D, E, and DE scores were examined. Receiver
operating characteristic curves were created to
investigate whether D, E, and DE scores or ADC
measurements indicate benign or malignant
properties.
Statistical analyses were performed using the
Japanese version of SPSS version 16.0 (IBM Japan,
Ltd., Tokyo, Japan).

3

Results

Sixty gliomas from 60 patients were included
in this study. The grade classification resulted in
17 grade I–II tumors, 12 grade III tumors, and
31 grade IV tumors.
3.1 ADC and Ki-67 staining index
A significant inverse relationship was found
between glioma proliferation and the mean ADC,
with low mean ADC values indicating a rapid
proliferation [Fig. 1(A), R2 = 0.1235, p = 0.008].
The same trend was also observed between
the minimum ADC value and Ki-67 index (R2 =
0.2316, p = 0.00017), with the minimum ADC as
a more significant indicator of potential glioma
proliferation than the mean ADC value [Fig. 1(B)].
3.2 MRI score and Ki-67 staining index
A significant difference in the mean Ki-67 staining
index was found between the D score 0 group
(26.1%) and D score 1 group (7.1%; p < 0.0001),
implying that gliomas with a high DWI signal
intensity tend to grow faster than those with
low signal intensities [Fig. 2(A)]. In the analysis
of contrast-enhanced images, a significant
difference was found between the E score 0
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Fig. 1 Correlation between the glioma Ki-67 index and ADC. (A) Correlation between the glioma Ki-67 index and mean ADC (p = 0.008).
(B) Correlation between the glioma Ki-67 index and minimum ADC (p = 0.00017).

Fig. 2

Comparison of the Ki-67 index in different MRI scores groups. (A) Comparison of the Ki-67 index in D score 0 and 1 group gliomas.

The difference is significant (p < 0.0001). (B) Comparison of the Ki-67 index between the E score 0 and 1 glioma groups. The difference is
significant (p = 0.0005). (C) Comparison of the Ki-67 index among the DE score 0, 1, and 2 glioma groups. Significant differences occur
between the DE score 0 and 2 groups (p < 0.0001) and between the DE score 0 and 1 groups (p = 0.004). There is no significant difference
between the DE score 1 and 2 groups (p = 0.077).

group (23.3%) and E score 1 group (7.0%; p =
0.0005), demonstrating that gliomas with a high
contrast-enhanced signal intensity proliferate
rapidly [Fig. 2(B)]. A scatter chart of the Ki-67
staining index in the DE score 0 (26.5%), DE
score 1 (12.6%), and DE score 2 (4.6%) groups is
presented in Fig. 2(C). Significant differences were
found between the DE score 0 and DE score
2 groups (p < 0.0001) and between the DE score 0
and DE score 1 groups (p = 0.004). However, no
significant difference was found between the DE
score 1 and DE score 2 groups (p = 0.077).
3.3 ADC and pathological grade
The comparisons of the three pathological grade
groups with respect to the mean and minimum
ADCs are shown in Figs. 3(A) and (B). There
was no significant difference in the mean ADC
between each pathological grade group (grade

http://bsa.tsinghuajournals.com

I–II: 1.399, grade III: 1.280, grade IV: 1.254),
although a significant difference in minimum ADC
was observed between the grade I–II and grade
III groups (p = 0.012) and between the grade I–II
and grade IV groups (p = 0.002). However, there
was no significant difference in minimum ADC
between the grade III and grade IV groups (grade
I–II: 0.860, grade III: 0.722, grade IV: 0.699).
No significant difference in the mean ADC
was found between the benign (grade I–II, 1.399)
and malignant groups [grade III–IV, 1.261; p =
0.055; Fig. 3(C)]; however, a significant difference
in minimum ADC was found between these
groups [0.860 vs. 0.706; p = 0.001; Fig. 3(D)].
The ADC receiver operating characteristic
curves of pathological grades I–II and III–IV are
shown in Fig. 4. The minimum ADC had an area
under the curve of 0.806 (95% CI 0.693–0.918),
whereas that of the mean ADC was 0.679 (95% CI
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Comparison of ADC among different groups. (A) Comparison of the mean ADC among grade I–II, grade III, and grade IV groups.

No significant difference was found between any group. (B) Comparison of the minimum ADC among grade I–II, grade III, and grade IV
groups. The differences between the grade I–II and grade III groups (p = 0.012) and between the grade I–II and grade IV groups (p = 0.002)
are significant. No significant difference was found between the grade III and grade IV groups. (C) Comparison of the mean ADC between
the benign and malignant groups. No significant difference was found (p = 0.055). (D) Comparison of the minimum ADC between the
benign and malignant groups. The difference is significant (p = 0.001).

Fig. 4

Receiver operating characteristic curves show that the

p-values < 0.0001). The D, E, and DE scores for
the malignant and benign groups were also
calculated. A significant difference was found
between the malignant and benign groups for
each score (all p-values < 0.0001). The receiver
operating characteristic curves for the D, E, and
DE scores and ADC are shown in Fig. 5, with
each score demonstrating a significant precision
accuracy for tumor classification.

minimum ADC is superior to the mean ADC for determination of
the malignant potential of gliomas.

0.542–0.817). The minimum ADC was superior
to the mean ADC for determination of the
malignant potential of gliomas.
3.4 MRI score and pathological grade
The D, E, and DE scores for each pathological
grade were calculated. Pearson’s chi-squared
test showed significant differences between
the pathological grades for each score (all

Fig. 5 Evaluation of the accuracy of the minimum ADC and D, E,
and DE scores.
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Discussion

DWI is usually used to detect acute ischemic
lesions. In tumor tissues, high cellularity is a
feature of malignancy; this limits the diffusion of
water molecules and leads to a high DWI signal
intensity and low ADC values in malignant
gliomas [9, 10]. In this study, both the mean and
minimum ADCs were significantly negatively
correlated with the Ki-67 staining index. The
Ki-67 staining index in the group with a D score
of 0 was significantly higher than that in the group
with a D score of 1. These findings indicate that
a low diffusion of water molecules is suggestive
of high tumor malignancy. The same relationship
was confirmed between the D scores and
pathological grades.
Various studies evaluated the degree of water
diffusion as a marker of glioma malignancy [1–15],
and similar to the current study, they generally
placed an ROI within the tumor, excluding the
cystic components and hemorrhage, and then
quantitatively measured the ADC within the ROI
[16, 17]. In this study, the ROI was positioned in
the largest section of the tumor, whereas most
previous studies used relatively small ROIs, which
were then summed. Some studies examined the
mean ADC [2, 3, 6, 7, 9, 10], whereas others
focused on the minimum ADC [11–15]. In this
study, there was a significant correlation between
the mean ADC and Ki-67 staining index, showing
that low mean ADC values were related to high
Ki-67 index values; however, no significant
correlation was observed between the mean
ADC and pathological grade.
In tumor tissues, vasogenic edema and degeneration (including intratumoral hemorrhage
and cystic alteration) are intermingled, and these
microscopic changes will inevitably be included
in the ROI. Such histological degeneration causes
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heterogeneity in ADC measurements, which may
lead to the recovery of low ADCs. Therefore, in
some instances, the mean ADC may not reflect
the pathological grade of gliomas [18, 19].
To avoid this phenomenon, the minimum
ADC within an ROI was measured, and the
most malignant tumor part was localized. The
minimum ADC was reported to be correlated
negatively with the grade and prognosis of
gliomas [12–15]. According to a report by Kim HS
and Kim SY [12], the sensitivity and specificity
for the determination of glioma grades with a
minimum ADC were 90.9 and 81.8, respectively,
with a threshold value of 0.98 × 10–3 mm/s2. In the
present study, there was a significant difference
in the minimum ADC between the grade I–II
and grade III groups and between the grade
I–II and grade IV groups. However, there was
no significant difference in the minimum ADC
between the grade III and grade IV groups. The
receiver operating characteristic curves showed
that ADC, especially the minimum ADC, was
very informative in distinguishing benign from
malignant gliomas.
Receiver operating characteristic curves were
constructed to compare the accuracies of the
D, E, and DE scores and minimum ADC for
the determination of the malignant potential of
gliomas. A comparison of the areas under the
receiver operating characteristic curves demonstrated that the D score was superior to the
minimum ADC (0.862 vs. 0.806, p < 0.05). The
area for the DE score was wider than that of
the D score (0.881 vs. 0.862), but the difference
was not significant. The E score demonstrated
a narrower area than the others (Fig. 5). These
findings demonstrated that DWI is very useful in
determining the malignant potential of gliomas.
Although the DE and D scores showed a similar
accuracy in determining the malignant potential
of gliomas, DWI is more convenient and intuitive
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for clinical doctors than the combination of DWI
and contrast-enhanced imaging [20]. Thus, the
D score is considered very informative in this
case.
One reason why the D score is superior to
ADC may be that the D score was calculated
using all tumor-containing slices, whereas ADC
was measured in only one slice showing the
maximum tumor size. It is possible that the same
accuracy could be obtained by measuring the
ADC in all slices; however, this procedure is very
time-consuming [21, 22].
In clinical practice, it may be difficult to
determine whether the signal intensity on DWI
is high because of the relatively unclear tumor
characteristics compared with gadoliniumenhanced images; benign tumors with the T2
shine-through phenomenon may be interpreted
as malignant tumors. An accurate determination
of tumor malignancy is critical for patients;
therefore, both DWI and gadolinium-enhanced
imaging should be performed for an accurate
imaging-based diagnosis of brain tumors.
In this study, the Ki-67 staining index was used
as a proliferative marker. Recently, molecular
pathological studies, including IDH status and
1p/19q codeletion, are required to precisely
diagnose central nervous system tumors, as shown
in World Health Organization classification.
Further investigation concerning the relationship
among histological grading, proliferative potential,
molecular status, and MRI findings should be
conducted for a larger number of malignant
glioma cases.

5

same tendency, but it was inferior to the minimum
ADC. The qualitative evaluation of the D score of
water molecule diffusion from DWI accurately
reflected the pathological grade of gliomas, and
a high signal intensity on DWI is useful in
determining the malignant potential of gliomas.
This evaluation is not inferior to quantitative
analysis using the minimum ADC. The E score
from the qualitative evaluation of gadolinium
enhancement can reflect the pathological
malignancy grade; however, the E score was
inferior to the D score. The DE score obtained
by combining the D and E scores had a similar
diagnostic accuracy to the D score. Based on the
finding that even benign tumors have high signal
intensities on DWI due to the T2 shine-through
phenomenon, gadolinium-enhanced images
should still be considered essential for the
diagnosis of tumor malignancy.
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Conclusions

The minimum ADC was found to be negatively
correlated with the Ki-67 staining index, and a
low minimum ADC was suggestive of tumor
malignancy. The mean ADC also showed the
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